Alliance launch UK’s first prescription drug for nausea during pregnancy

Roche’s MabThera approved in Europe for pemphigus vulgaris
Credit: Piotr Adamowicz

Alliance Pharma has launched what it claims is the UK’s only prescription treatment for vomiting and nausea during pregnancy.

Sold under the brand name Xonvea, Diclectin was licensed from Canadian pharma firm Duchesnay in 2015 and has been prescribed to 33 million women over 40 years.

Marketing approval from the Medicines and Healthcare products Regulatory Agency was granted over the summer.

Nausea and vomiting are the most common medical condition during pregnancy and affects around 40% of women.

Alliance Chief Exec Peter Butterfield said: “There is no other licensed treatment for nausea and vomiting of pregnancy in the UK so this is excellent news for patients and clinicians as it fulfils a significant unmet medical need.”